Follow
Fatih Oğuz Önder
Fatih Oğuz Önder
Verified email at acibadem.edu.tr - Homepage
Title
Cited by
Cited by
Year
Age-and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review
M Toy, FO Önder, T Wörmann, AM Bozdayi, SW Schalm, GJ Borsboom, ...
BMC infectious diseases 11, 1-12, 2011
1842011
Treatment of chronic delta hepatitis with lamivudine vs lamivudine + interferon vs interferon
C Yurdaydın, H Bozkaya, FO Önder, H Şentürk, H Karaaslan, M Akdoğan, ...
Journal of Viral Hepatitis 15 (4), 314-321, 2008
1702008
Interferon treatment duration in patients with chronic delta hepatitis and its effect on the natural course of the disease
C Yurdaydin, O Keskin, Ç Kalkan, F Karakaya, A Çalişkan, G Kabaçam, ...
The Journal of infectious diseases 217 (8), 1184-1192, 2018
992018
Gülveren lisesi son sınıf öğrencilerinin bazı beslenme alışkanlıklarının saptanması ve bunun malnütrisyon prevalansı ile olan ilişkisi
F ÖNDER, M KURDOĞLU, G OĞUZ, B ÖZBEN SADIÇ, S ATİLLA, S ORAL
Toplum Hekimliği Bülteni 21 (1), 2000
792000
A pilot study of 2 years of interferon treatment in patients with chronic delta hepatitis
C Yurdaydın, H Bozkaya, H Karaaslan, FO Önder, ÖE Erkan, K Yalçın, ...
Journal of viral hepatitis 14 (11), 812-816, 2007
762007
HB eAg‐positive hepatitis delta: virological patterns and clinical long‐term outcome
B Heidrich, B C. Serrano, R Idilman, G Kabaçam, B Bremer, R Raupach, ...
Liver International 32 (9), 1415-1425, 2012
752012
Entecavir treatment of chronic hepatitis D
G Kabaçam, FO Önder, M Yakut, G Seven, SC Karatayli, E Karatayli, ...
Clinical infectious diseases 55 (5), 645-650, 2012
632012
The cost-effectiveness of treating chronic hepatitis B patients in a median endemic and middle income country
M Toy, FO Onder, R Idilman, G Kabacam, JH Richardus, M Bozdayi, ...
The European Journal of Health Economics 13, 663-676, 2012
392012
Fatigue of cholestasis and the serotoninergic neurotransmitter system in the rat
T Çelik, MZ Gören, K Çınar, H Gürdal, FO Önder, A Tan, B Terzioğlu, ...
Hepatology 41 (4), 731-737, 2005
312005
Optimal timing of adjuvant treatment in patients with early breast cancer
N Alkis, AG Durnali, UY Arslan, M Kocer, FO Onder, S Tokluoglu, ...
Medical Oncology 28, 1255-1259, 2011
302011
Twice a day quadruple therapy for the first-line treatment of Helicobacter pylori in an area with a high prevalence of background antibiotic resistance
AS Köksal, FO Onder, S Torun, E Parlak, A Sayilir, O Tayfur, H Yildiz, ...
Acta gastro-enterologica Belgica 76 (1), 34-37, 2013
282013
The impact of endoscopic retrograde cholangiopancreatography education on radiation exposure to experienced endoscopist:“trainee effect”
E Oztas, E Parlak, F Kucukay, M Arhan, U Daglı, DO Etik, FO Onder, ...
Digestive diseases and sciences 57, 1134-1143, 2012
252012
Can serum ST2 levels be used as a marker of fibrosis in chronic hepatitis B infection?
E Oztas, UB Kuzu, NI Zengin, IH Kalkan, F Saygili, H Yildiz, HT Celik, ...
Medicine 94 (47), e1889, 2015
242015
Evaluation of preoperative predictors of development of pouchitis after ileal-pouch-anastomosis in ulcerative colitis
IH Kalkan, Ü Dağli, FO Önder, B Tunç, E Öztaş, A Ülker, N Şaşmaz
Clinics and research in hepatology and gastroenterology 36 (6), 622-627, 2012
232012
Chronic intestinal pseudo-obstruction and neurological manifestations in early adulthood: considering MNGIE syndrome in differential diagnosis
E Oztas, Y Ozin, F Onder, IK Onal, D Oguz, C Kocaefe
J Gastrointestin Liver Dis 19 (2), 195-7, 2010
222010
Aflatoxin exposure in viral hepatitis patients in Turkey
D Mizrak, B Engin, F ÖNDER, B Yener, M Bektaş, Z Biyikli, R Idilman, ...
Turkish Journal of Gastroenterology 20 (3), 2009
212009
Ki67 as a prognostic factor for long-term outcome following surgery in gastrointestinal stromal tumors
NT Kucukmetin, B Cicek, M Saruc, O Ersoy, E Vardareli, O Onder, ...
European journal of gastroenterology & hepatology 27 (11), 1276-1280, 2015
202015
Topical application of ankaferd hemostat in a patient with gastroduodenal amyloidosis complicated with gastrointestinal bleeding
Y Beyazit, FO Onder, S Torun, A Tas, T Purnak, I Tenlik, N Turhan
Blood Coagulation & Fibrinolysis 24 (7), 762-765, 2013
112013
ENTECAVIR MAY BE BENEFICIAL IN A SUBSET OF PATIENTS WITH CHRONIC DELTA HEPATITIS: 913
FO Onder, M Yakut, R Idilman, G Seven, G Kabaçam, E Karatayli, ...
Hepatology 50, 735A, 2009
112009
Features of systemic lupus erythematosus in patients with autoimmune hepatitis
FO Önder, ÖT Yürekli, E Öztaş, İH Kalkan, AŞ Köksal, M Akdoğan, ...
Rheumatology international 33, 1581-1585, 2013
92013
The system can't perform the operation now. Try again later.
Articles 1–20